• A controlled study investigated the relationship between steady-state plasma and RBC concentrations of the phenothiazine derivative butaperazine maleate and the therapeutic response in 24 hospitalized schizophrenic patients who received constant maintenance doses of butaperazine during the first two weeks of treatment. Butaperazine concentrations in RBCs correlated significantly with clinical improvement in an inverted U-shaped pattern, whereas plasma levels of butaperazine were not significantly related to clinical response. Both plasma and RBC levels of butaperazine showed large interpatient variations. The level of RBC-bound drug might be a better peripheral correlate of drug levels in the brain than are drug levels in plasma. Thus, monitoring drug levels in RBCs might have an advantage over measuring drug levels in plasma. These findings might not allow generalization to other antipsychotic agents.
Casper R, Garver DL, Dekirmenjian H, Chang S, Davis JM. Phenothiazine Levels in Plasma and Red Blood Cells: Their Relationship to Clinical Improvement in Schizophrenia. Arch Gen Psychiatry. 1980;37(3):301–305. doi:https://doi.org/10.1001/archpsyc.1980.01780160071008
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: